Joon Ha

Joon Ha

Auto-generated profile, based on publicly available information

Joon Ha

Department of Orthopaedics, King's College Hospital, London, UK

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2013 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
SCSimon J. Cole
Simon J. Cole
HMHugh Mackenzie
Hugh Mackenzie
JHJoon Ha
Joon Ha
GHGeorge B. Hanna
George B. Hanna
DMDanilo Miskovic
Danilo Miskovic

1 May 2020 in Journal of Clinical Orthopaedics and Trauma
Verified
Journal Article
Closed access
JHJoon Ha
Joon Ha
THThomas Hester
Thomas Hester
RFRobert Foley
Robert Foley
IRInes L.H. Reichert
Ines L.H. Reichert
PVPrashanth R.J. Vas
Prashanth R.J. Vas
VKVenu Kavarthapu
Venu Kavarthapu

7 November 2024 in The Lancet Diabetes & Endocrinology
Verified
Journal Article
Closed access
MBMichael Bergman
Michael Bergman
MAMuhammad Abdul-Ghani
Muhammad Abdul-Ghani
JCJuliana Chan
Juliana Chan
MSMaria Inês Schmidt
Maria Inês Schmidt
JHJoon Ha
Joon Ha
JTJaakko Tuomilehto
Jaakko Tuomilehto

1 June 2021 in Journal of Clinical Orthopaedics and Trauma
Verified
Journal Article
Closed access
WNWilliam J. Nash
William J. Nash
THThomas Hester
Thomas Hester
JHJoon Ha
Joon Ha

1 July 2021 in Journal of Clinical Orthopaedics and Trauma
Verified
Journal Article
Closed access
JHJoon Ha
Joon Ha
PPPriya Parekh
Priya Parekh
DGDavid Gamble
David Gamble
JMJames Masters
James Masters
PJPeter Jun
Peter Jun
MHMansur Halai
Mansur Halai

22 November 2024 in International Orthopaedics
Verified
Journal Article
Open access
PDF file
JPJae Yong Park
Jae Yong Park
JCJames Andrew Ng Hing Cheung
James Andrew Ng Hing Cheung
DTDominik Todorov
Dominik Todorov
SPShin Young Park
Shin Young Park
HLHayeon Lim
Hayeon Lim
JHJoon Ha
Joon Ha
Purpose: Biological augmentation of anterior cruciate ligament (ACL) reconstruction with bone marrow aspirate concentrate (BMAC) is gaining attention for its theoretical potential to enhance postoperative healing and recovery. However, its clinical benefits remain uncertain, and its high cost raises questions about efficacy. Hence, we systematically reviewed randomised controlled trials (RCTs) to evaluate the effectiveness of BMAC in ACL reconstruction. Methods: Our search included Cochrane, EMBASE, OVID, PubMed, and Scopus databases for RCTs evaluating the use of BMAC in ACL reconstruction. Primary outcomes focused on International Knee Documentation Committee (IKDC) scores and Lysholm scores. Secondary outcomes included MRI-related outcomes and postoperative complications. Statistical analysis was conducted using Review Manager 5.4 (Cochrane Collaboration), with heterogeneity assessed using Cochrane’s Q test and I2 statistics. Results: 221 patients from five RCTs were included, with 109 (49.3%) receiving BMAC augmentation. Follow-up ranged from 11.05 to 24 months. No significant differences were found in postoperative IKDC scores between the BMAC and control groups at, three, six and 12 months. The BMAC group had significantly higher IKDC scores at 24 months; however, this difference was unlikely to be clinically significant. No significant differences were observed in postoperative Lysholm scores at 12 or 24 months. MRI-related outcomes suggested potential graft recovery improvement with BMAC, and complication rates were comparable between groups. Conclusion: In summary, biological augmentation with BMAC in ACL reconstruction does not significantly improve early patient-reported outcomes but offers potential benefits in graft recovery without increasing complication rates.